BRD4 and sarcoma: We found two molecules supporting an EWSR1-ATF1 gene fusion in a pediatric sarcoma patient (SAR-pt01, VAF = 0.0016) showing metastatic lesions in the lung and one molecule supporting a NUTM1-BRD4 gene fusion in a pediatric patient diagnosed with stage IV NUT midline carcinoma and widespread metastatic lesions (NMC-pt01, VAF = 0.0013) (Tables 1 and 3).